Your Source for Venture Capital and Private Equity Financings

Alamar Biosciences Completes $80M Series B

2021-09-08
FREMONT, CA, Alamar Biosciences, a precision proteomics company, has closed its $80 million Series B financing round led by Sherpa Healthcare Partners.
Alamar Biosciences, a precision proteomics company that brings both ultra-high sensitivity and massively parallel scale to proteomic analysis, has closed its $80 million Series B financing round, bringing its total funding to $110 million.

The Series B financing round was led by Sherpa Healthcare Partners and included Morningside Ventures, Samsara Biocapital, and existing investors Qiming Venture Partners and Illumina Ventures.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors